|
and can be regarded as extension of related results of Runge-Kutta methods obtained by Hairer and Wanner(98),Sun(99 ),Chan(990),Grimm and Scherer(00 )and so on. |
中文意思: 和 可看作是Hairer和Wanner(98)、Sun(99 )、Chan(990)、Grimm和Scherer(00 )等人获得的相应结果的推广或发展。 |
以下为相关句子列表(点击查看,可以看对应的解释):
|
|
The to tal decrease rate of migraine attacks (%) of therapeutic group and placebo group were .9±0. and .0±0.(Z=.7,P<0.00), respectively. It has marked statist ical difference (P<0.00).
|
|
|
治疗组和安慰剂组总发作次数减少率 ( % )分别为 9± 0 和 0± 0 ,两组比较差异有显著意义 (Z = 7,P <0 0 0 )。 |
|
Therapeutics by virazole and energy mistura two weeks later,ALT returned to normal in 0 cases(90.9%);
|
|
|
经病毒唑及能量合剂等治疗后,周内ALT恢复正常者0例,占全部AST升高病例的90.9%; |
|
Thyroidal follicular cell colliod increased obviously on the st day after pinealectomy.
|
|
|
去松果体后天,大鼠甲状腺滤泡上皮细胞吞噬的胶体颗粒明显增多; |
|
Total scores of BpRS、HAMD、CGI and ITAQ were significantly correlated with SSICA, and ITAQ was helpful to differentiate the two groups with or without competence of informed consent (OR=.7 );
|
|
|
BPRS、HAMD、CGI及ITAQ总分与知情同意能力显著相关(p<0.0),ITAQ分有助于区分有、无知情同意能力(OR=.7 ); |
|
Under the stress ratio R=0,the corresponding fatigue design S-N curve(attributed by hot spot stress,m=0) of low carbon steel and austenite stainless steel Cr8Ni9Ti tubular joints treated by ultrasonic peening before loading is lgN= 0.78-0lgS.
|
|
|
当应力比R=0,0钢及奥氏体不锈钢Cr8N i9Ti承载前超声冲击处理管接头的相应疲劳设计S-N曲线(热点应力表征)为lgN= 0.78-0 lgS; |
|
and can be regarded as extension of related results of Runge-Kutta methods obtained by Hairer and Wanner(98),Sun(99 ),Chan(990),Grimm and Scherer(00 )and so on.
|
|
|
和 可看作是Hairer和Wanner(98)、Sun(99 )、Chan(990)、Grimm和Scherer(00 )等人获得的相应结果的推广或发展。 |
|
arterio portal fistula;
|
|
|
肝动脉门静脉瘘 ; |
|
aural symptoms (otalgia,deafness or hemorrhage in the external auditory canal);
|
|
|
伴耳痛、耳聋、外耳道少量出血; |
|
because of the scientific nature of analysis on accrual basis, it must be combined with the information of cash flow;
|
|
|
由于应计制分析方法的科学性,必须将现金流量信息与应计制信息结合; |
|
externa endometriosis (EEM);
|
|
|
外在性子宫内膜异位症; |
|
kinases and related proteins;
|
|
|
激酶及其相关蛋白; |
|
|
|